Expected Results

  • the obtaining of at least 2 hydrogel formulations developed at the laboratory level;
  • 2 ISI articles (article or review) published in Q1 and Q2 classified journals;
  • 1 experimental protocol for in vitro evaluation of the effectiveness of hydrogel for the treatment of malignant melanoma;
  • 1 international conference participation;
  • 1 patent application.

Published on  December 5th, 2022